Ascendis Pharma A/S (Nasdaq: ASND) today announced that pivotal Week 52 results from its randomized double-blind, ...

Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

The Company’s new Deep TMS 360 technology has been designed to provide more comprehensive and uniform stimulation of the ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

Objective To assess the effects of behaviourally informed short message service (SMS) reminders on demand for human ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

On Monday, US Health and Human Services Secretary Robert F. Kennedy Jr. and US Food and Drug Administration Commissioner Dr. Marty Makary announced that after 20 years, they ...

Alex McDonald, MD, sits down with pediatric oncologist Neha Vaghasia, MD, to explore the landscape of oncology clinical trials. They break down the phases of trials, discuss when physicians typically ...

Introduction Hospitalisation represents an opportunity to identify and treat e-cigarette use among adolescents and young adults (AYAs). Knowledge on how to provide this care is lacking. We aim to fill ...